glp-1 drugs and muscle loss GLP-1R agonists use | Acta Diabetologica Glucagon-like peptide-1 receptor agonists and

Discover what the evidence says about berberine, fibre, omega-3, and other natural compounds, plus important safety advice and when to see your GP.

The most striking protective effects of SGLT2is were a marked reduction in hospitalization for heart failure and a remarkable reduced progression of chronic kidney disease

We report an unusual case of diabetic ketoalkalosis, a mixed acid-base disorder, in a 57-year-old female patient with insulin-dependent T2DM following a switch to Mounjaro (tirzepatide)

Simple Comparison between upcoming Monthly GLP-1s: By Amgen and Pfizer The Monthly Obesity Treatment Race Is Heating Up The next wave of obesity pharmacotherapy may not be about achieving greater efficacy aloneit may also be about achieving it with less frequent dosing

GLP-1 medications such as Ozempic and Wegovy have significantly reshaped the weight loss market by improving blood sugar regulation, insulin sensitivity, and appetite control

Discover how GLP-1 medications help fatty liver disease through clinical evidence, FDA-approved options, patient selection criteria, and monitoring protocols for MASLD and NASH treatment.